|
|
SPOT ON
|
|
Varicella vaccination: What's new?
|
|
|
NEW ON THE MARKET
|
|
Lurasidone (LATUDA) for schizophrenia
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
On the duration of dual antiplatelet therapy after drug-eluting stents
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Update on mitoxantrone (RALENOVA) for multiple sclerosis
|
|
|
IN BRIEF
|
|
Marketing authorisations of 80 generic drugs suspended in Germany due to falsified bioequivalence trials from India
Reports of deaths in Italy - FLUAD rehabilitated
Adulterated dietary supplements - no end in sight
European Commission - medical devices now, after all, belong to the industry directorate
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Diverticulitis with denosumab (PROLIA)
|
|
|
SIDE EFFECTS
|
|
Hangover: initial dose of zopiclone (e.g. XIMOVAN) halved in Canada
|
|
|
e a-t IN INTERNET
|
|
Advertising for the intranasal flu vaccine FLUENZ in kindergartens
|
|